两个带呋喃悬臂不对称大环双核铜配合物的合成、结构及性质

合成并表征了2个不对称大环双核铜配合物[Cu₂（L¹）Cl₂]·CH₃CN（1）和[Cu₂（L²）Br₂]·CH₃CN·H₂O（2）。配合物与CT-DNA的作用通过紫外-可见光谱,粘度实验,圆二色谱和凝胶电泳实验进行了研究。紫外-可见光谱的结果表明配合物与DNA的结合常数分别为6.2×10⁵和7.2×10⁵,圆二色谱的实验表明配合物能与DNA较好的结合,粘度实验表明配合物与DNA的结合为非典型的插入模式,凝胶电泳实验显示配合物通过氧化机理对DNA有较强的切割活性。     

一种含吲哚咪唑基Ru(II)配合物的酸碱性质和与DNA相互作用的研究

合成了一个新的Ru(II)配合物[Ru(bpy)₂(H₂iip)](ClO₄)₂•5H₂O [bpy＝2,2'-联吡啶, H₂iip＝2-吲哚基-咪唑并[4,5-ƒ][1,10]-邻菲罗啉]. 通过酸碱滴定发射光谱测定了该配合物的表观电离常数; 用紫外可见光谱、荧光光谱、稳态荧光淬灭、溴化乙锭竞争键合、粘度测量和DNA裂解实验研究了配合物与DNA的相互作用性质. 结果表明配合物以经典的插入模式与DNA键合, 键合常数K_b＝(5.97±0.27)×10⁵ mol^－1•L (50 mmol/L NaCl).     

一种含吲哚咪唑基Ru(II)配合物的酸碱性质和与DNA相互作用的研究

合成了一个新的Ru(II)配合物[Ru(bpy)₂(H₂iip)](ClO₄)₂•5H₂O [bpy＝2,2'-联吡啶, H₂iip＝2-吲哚基-咪唑并[4,5-ƒ][1,10]-邻菲罗啉]. 通过酸碱滴定发射光谱测定了该配合物的表观电离常数; 用紫外可见光谱、荧光光谱、稳态荧光淬灭、溴化乙锭竞争键合、粘度测量和DNA裂解实验研究了配合物与DNA的相互作用性质. 结果表明配合物以经典的插入模式与DNA键合, 键合常数K_b＝(5.97±0.27)×10⁵ mol^－1•L (50 mmol/L NaCl).     

两个带呋喃悬臂不对称大环双核铜配合物的合成、结构及性质(英文)

合成并表征了2个不对称大环双核铜配合物[Cu2(L1)Cl2]·CH3CN(1)和[Cu2(L2)Br2]·CH3CN·H2O(2)。配合物与CT-DNA的作用通过紫外-可见光谱,粘度实验,圆二色谱和凝胶电泳实验进行了研究。紫外-可见光谱的结果表明配合物与DNA的结合常数分别为6.2×105和7.2×105,圆二色谱的实验表明配合物能与DNA较好的结合,粘度实验表明配合物与DNA的结合为非典型的插入模式,凝胶电泳实验显示配合物通过氧化机理对DNA有较强的切割活性。     

全反式维甲酸合铜(II)配合物对DNA的切割和键合作用

以荧光法、粘度法、凝胶电泳和电化学方法研究了全反式维甲酸合铜(II)配合物与DNA的作用. 结果表明, 该配合物能在生理条件下有效切割质粒DNA, 加入H₂O₂后发现该配合物的切割活性增强, 说明该配合物对DNA的切割机理可能有两种: 氧化和水解. 同时可使DNA的粘度增加, 使EB-DNA体系的荧光强度降低. DNA的存在能导致该配合物氧化还原峰电流降低. 据此推断, 该配合物主要以嵌入方式与DNA作用.     

4-氯-2-(1H-咪唑并[4,5-f][1,10]菲咯啉)苯酚铜(Ⅱ)配合物的晶体结构及其与DNA的相互作用

利用菲咯啉酮衍生物4-氯-2-(1H-咪唑并[4,5-f][1,10]菲咯啉)苯酚(HL)设计合成了一种新的单核铜配合物[Cu (L)(5-Cl-sal)(DMF)]ClO₄·DMF (5-Cl-Hsal=5-氯-水杨醛),用元素分析和X射线单晶衍射等手段对配合物进行了表征。该配合物晶体属三斜晶系,P1空间群。用紫外吸收光谱、荧光光谱和凝胶电泳等方法研究了配合物与DNA的相互作用。结果表明,配合物以插入方式与CT-DNA结合,结合常数为1.02×10³ L·mol^-1。同时配合物也能较大程度淬灭EB-DNA复合物的荧光,表观键合常数为4.37×10⁵ L·mol^-1,略小于经典键合常数10⁷ L·mol^-1。淬灭机理为动态淬灭。凝胶电泳实验研究表明配合物在H₂O₂存在下可将pBR322质粒DNA切割为开环缺口型DNA和线型DNA,配合物浓度越大,切割效果越好。机理研究显示,配合物切割DNA的反应是由羟基自由基(·OH)和单线态氧(¹O₂)作为活性物种的氧化切割过程。     

一个嫁接有羧酸羟基乙基酯的二吡啶吩嗪Ru(II)配合物的合成、与DNA的相互作用以及溶剂变色性质的研究

合成并表征了一个新的Ru(II)配合物[Ru(bpy)₂(hedppc)](ClO₄)₂ {bpy＝2,2'-联吡啶, hedppc＝二联吡啶[3,2-a: 2',3'-c]吩嗪-11-羧酸(2-羟乙基)酯}. 通过紫外-可见吸收光谱、与溴化乙锭竞争实验、粘度测量和DNA裂解实验研究了配合物与小牛胸腺DNA的相互作用性质. 结果表明配合物以插入模式与DNA键合，键合常数K_b＝(6.99±1.34)×10⁶ mol^－1•L (s＝2.03±0.04)与母体配合物[Ru(bpy)₂ (dppz)]^2＋相近，但光致发光和溶剂变色等光学性质与[Ru(bpy)₂ (dppz)]^2＋有明显的差别.     

钌(Ⅱ)配合物[Ru(dpq)2L]4+的合成、晶体结构及与G-四链体DNA的相互作用

以cis-[Ru(dpq)₂Cl₂]·2H₂O(dpq=二吡啶[3,2-d:2',3'-f]二氮萘)为原料与5,5'-二(1-(三乙胺)甲基)-2,2'-联吡啶阳离子(L)合成钌(Ⅱ)配合物[Ru(dpq)₂L](PF₆)₄,并研究了该配合物与G-四链体DNA的作用:FRET实验表明,配合物对人端粒DNA h-telo具有选择性,其作用能力要强于同癌基因启动子区域的四链DNA,如c-myc和bcl2;CD光谱表明,在Na⁺和K⁺都不存在的情况下,配合物能诱导h-telo形成平行结构;此外,紫外和发射光谱都显示,配合物在K⁺溶液中与h-telo的作用力要大于在Na⁺溶液中的。     

一例由多齿席夫碱构筑的Tb2配合物的结构、荧光性质及生物活性

使用多齿希夫碱配体 H₄L(H₄L=N'',N″-((1E,1''E)-(1,10-菲咯啉-2,9-二酰基)双(亚甲基)双(2-羟基苯甲酰肼))与 Tb(acac)₃·2H₂O反应(acac^-=乙酰丙酮根),通过溶剂热法,设计并合成了一例结构新颖的双核铽配合物[Tb₂(L)(H₂L)]·2CH₃OH·CH₃CN (1),并研究了该配合物的结构、荧光性质及生物活性。单晶X射线衍射分析表明该配合物主要含有2个Tb^Ⅲ离子和2个失去不同质子的配体离子(L^4-和H₂L^2-)。中心Tb1和Tb2离子都是九配位的,其几何构型呈现扭曲的呼啦圈形。固体荧光实验测试结果表明：该配合物在室温下表现出Tb^Ⅲ离子的荧光特征发射峰。生物活性研究表明,与配体H₄L和稀土离子相比较,配合物具有更强的抗菌活性。采用紫外可见光谱法、循环伏安法、凝胶电泳法和荧光光谱法研究了该配合物与小牛胸腺DNA之间的相互作用,结果表明配合物主要以插入作用的方式与小牛胸腺DNA结合。     

新型双核配合物的形成、与DNA的作用机制及荧光性质研究

利用紫外、荧光和粘度等方法研究了含不同配体的钌(II)配合物[Ru(phen)₂CImP]^2＋(CImP＝3,4-二羟基-咪唑并[4,5-i][1,10]邻菲咯啉)和[Ru(phen)₂TPPZ]^2＋(TPPZ＝四吡啶[3,2-a:2',3'-c:3',2'-h:2',3'-j]吩嗪)与DNA的作用机制, 并研究了配合物与Zn^2＋配合后荧光性质变化. 结果表明[Ru(phen)₂TPPZ]^2＋与DNA以插入模式作用, 而[Ru(phen)₂CImP]^2＋与DNA则以沟面结合模式作用. 向配合物溶液中滴加Zn^2＋后, 配合物[Ru(phen)₂TPPZ]^2＋和[Ru(phen)₂CImP]^2＋均可以与Zn^2＋形成双核配合物[Ru(phen)₂(TPPZ)Zn]^4＋和[Ru(phen)₂(CImP)Zn]^4＋, 配合物的荧光减弱. 与DNA作用后, 配合物仍可以与Zn^2＋配位形成双核配合物, 但[Ru(phen)₂(TPPZ)Zn]^4＋保持插入模式与DNA作用, 配合物的荧光减弱. 而[Ru(phen)₂(CImP)Zn]^4＋与DNA则由沟面结合改为插入结合, 配合物的荧光增强.     

一个嫁接有羧酸羟基乙基酯的二吡啶吩嗪Ru(II)配合物的合成、与DNA的相互作用以及溶剂变色性质的研究

合成并表征了一个新的Ru(II)配合物[Ru(bpy)₂(hedppc)](ClO₄)₂ {bpy＝2,2'-联吡啶, hedppc＝二联吡啶[3,2-a: 2',3'-c]吩嗪-11-羧酸(2-羟乙基)酯}. 通过紫外-可见吸收光谱、与溴化乙锭竞争实验、粘度测量和DNA裂解实验研究了配合物与小牛胸腺DNA的相互作用性质. 结果表明配合物以插入模式与DNA键合,键合常数K_b＝(6.99±1.34)×10⁶ mol^－1•L (s＝2.03±0.04)与母体配合物[Ru(bpy)₂ (dppz)]^2＋相近,但光致发光和溶剂变色等光学性质与[Ru(bpy)₂ (dppz)]^2＋有明显的差别.     

双核钌(II)多吡啶配合物与酵母RNA的相互作用研究

用紫外-可见吸收光谱和荧光光谱滴定、稳态荧光淬灭和反向盐滴定实验研究了双核钌(II)配合物[(bpy)₂Ru(ebipcH₂)Ru(bpy)₂](ClO₄)₄ {bpy＝2,2'-联吡啶; ebipcH₂＝N-乙基-4,7-二(咪唑-[4,5-f]-(1,10-邻菲啰啉)-2-基)咔唑}与酵母RNA的相互作用. 结果表明该双核配合物以插入方式与酵母RNA作用, 在生理盐浓度下(≈150 mmol/L NaCl)该配合物与RNA的相互作用明显强于DNA.     

Cyclometalated iridium(III) complex of 6‐hydroxydipyrido[3,2‐a:2′,3′‐c]phenazine: synthesis,and acid–base and avid DNA binding properties

A new cyclometalated Ir(III) complex [Ir(ppy)₂(hdppz)]PF₆ (Hppy = 2‐phenylpyridine and hdppz = 6‐hydroxydipyrido[3,2‐a:2′,3′‐c]phenazine) was synthesized and characterized. The pH effects on the UV–vis absorption spectra were studied and ground‐state acid ionization constant pK_a values of the complex were derived. The calf thymus DNA (ct‐DNA) binding properties of the complex were investigated with UV‐vis absorption spectrophotometric titrations, DNA competitive binding with ethidium bromide, DNA melting experiments, viscosity measurements and density functional theory (DFT) calculations. The complex was demonstrated to act as a ct‐DNA intercalator with a large DNA binding constant value of (6.06 ± 0.32) × 10⁶ M ⁻¹ in 50 mM NaCl. The avid DNA binding affinity observed was rationalized by the DFT calculations. Copyright © 2011 John Wiley & Sons, Ltd.     

Synthesis,Crystal Structure,DNA‐binding Properties and Antioxidant Activity of a Copper(II) Complex with Naphthalimide Schiff Base

The Schiff N‐allylamine‐4‐(ethylenediamine‐5‐methylsalicylidene)‐1,8‐naphthalimide (H₂L) and its copper(II) complex, [Cu(HL)₂] · 0.5DMF, were synthesized and characterized. The crystal structure of the Cu^II complex reveals a slightly distorted square‐planar arrangement provided by two N and O donors from two deprotonated ligands. In addition, the DNA‐binding properties of the ligand and Cu^II complex were investigated by fluorescence spectra, electronic absorption, and viscosity measurements. The experimental studies of the DNA‐binding properties indicated that the ligand and Cu^II complex reacted with DNA via intercalation binding mode, and binding affinity for DNA takes the order: ligand > Cu^II complex. The antioxidant assay in vitro suggested that both exhibited potential intensely antioxidant properties, and the ligand is more effective than its Cu^II complex.     

多吡啶锌配合物键合与切割DNA研究

The complex of Zn[(phen)(dione)Cl]ClO_4·H_2O(where phen is 1,10-phenanthroline and dione is 1,10-phenan-throline-5,6-dione)has been synthesized and characterized.The interaction of the complex with DNA was investi-gated using UV absorption,fluorescence spectroscopy and electrophoresis measurements.The results show that thecomplex mainly binds to the double helix of DNA with intercalation mode and the binding constant K is 2.4×10~4mol~(-1)·L.Moreover,the complex can efficiently cleave plasmid DNA at physiological pH and temperature.Thecleavage occurs via a hydrolysis mechanism,which is showed by adding radical scavengers,rigorously anaerobicexperiments,analysis for malondialdehyde-like products,and the hydrolysis experiment of BDNPP with a rate con-stant k_(obs)of 5.3×10~(-6)s~(-1).     

Synthesis,structural characterization and DNA-binding studies of a new cobalt (II) complex: (HAcr)<Subscript>4</Subscript>[Co(Sal)<Subscript>3</Subscript>]

A new cobalt (II) coordination compound was synthesized using proton transfer mechanism. The reaction between CoCl₂·2H₂O, Salicylic acid (H₂Sal) and acridine (Acr) gave a new coordination compound formulated as (HAcr)₄[Co(Sal)₃], which was characterized by elemental analysis, NMR, IR and UV/Vis spectroscopies. The interaction of this complex with DNA has been investigated in vitro using UV absorption, fluorescence spectroscopy, viscosity measurements and gel electrophoresis methods. The intrinsic binding constant has been estimated to be 5.8 × 10⁵ M^?1 using UV absorption. The interaction of DNA–Co (II) complex caused quenching in fluorescence. The binding constant, the number of binding site and Stern–Volmer quenching constant have been calculated to be 7.7 × 10⁴ M^?1, 1.143 and 1.5 × 10⁴ Lmol^?1, respectively. The increase in the viscosity of DNA with increasing the concentration of the Co (II) complex and the observations of other experiments suggest that the cobalt (II) complex binds to DNA by partial intercalation binding mode. Furthermore, the interaction of DNA–Co (II) complex was confirmed using gel electrophoresis studies. Moreover, molecular docking technique predicted partial intercalation binding mode for the complex.     

New anthracene based Schiff base ligands appended Cu(II) complexes: Theoretical study,DNA binding and cleavage activities

New anthracene based Schiff base ligands L ¹ and H( L ² ), their Cu(II) complexes [Cu( L ¹ )Cl₂] ( 1 ) and [Cu( L ² )Cl] ( 2 ) , (where L ¹  = N¹,N²‐bis(anthracene‐9‐methylene)benzene‐1,2‐diamine, L ²  = (2Z,4E)‐4‐(2‐(anthracen‐9‐ylmethyleneamino)phenylimino)pent‐2‐en‐2‐ol) have been prepared and characterized by elemental analysis, NMR, FAB‐mass, EPR, FT‐IR, UV–Vis and cyclic voltammetry. The electronic structures and geometrical parameters of complexes 1 and 2 were analyzed by the theoretical B3LYP/DFT method. The interaction of these complexes 1 and 2 with CT‐DNA has been explored by using absorption, cyclic voltammetric and CD spectral studies. From the electronic absorption spectral studies, it was found that the DNA binding constants of complexes 1 and 2 are 8.7 × 10³ and 7.0 × 10⁴ M^?1, respectively. From electrochemical studies, the ratio of DNA binding constants K₊/K₂₊ for 2 has been estimated to be >1. The high binding constant values, K₊/K₂₊ ratios more than unity and positive shift of voltammetric E_1/2 value on titration with DNA for complex 2 suggest that they bind more avidly with DNA than complex 1 . The inability to affect the conformational changes of DNA in the CD spectrum is the definite evidences of electrostatic binding by the complex 1 . It can be assumed that it is the bulky anthracene unit which sterically inhibits these complexes 1 and 2 from intercalation and thereby remains in the groove or electrostatic. The complex 2 hardly cleaves supercoiled pUC18 plasmid DNA in the presence of hydrogen peroxide. The results suggest that complex 2 bind to DNA through minor groove binding.     

Experimental and Theoretical Studies on DNA‐Binding and Spectral Properties of ‘Light Switch’ Complexes [Ru(L)2(ppn)]2+ (L=2,2′‐Bipyridine and 1,10‐Phenanthroline; ppn=Pteridino[6,7‐f] [1,10]phenanthroline‐11,13‐diamine)

The ligand pteridino[6,7‐f] [1,10]phenanthroline‐11,13‐diamine (ppn) and its Ru^II complexes [Ru(bpy)₂(ppn)]²⁺ ( 1 ; bpy=2,2′‐bipyridine) and [Ru(phen)₂(ppn)]²⁺ ( 2 ; phen=1,10‐phenanthroline) were synthesized and characterized by elemental analysis, electrospray MS, ¹H‐NMR, and cyclic voltammetry. The DNA‐binding behaviors of 1 and 2 were studied by spectroscopic and viscosity measurements. The results indicate that both complexes strongly bind to calf‐thymus DNA in an intercalative mode, with DNA‐binding constants K_b of (1.7±0.4)?10⁶ M ^?1 and (2.6±0.2)?10⁶ M ^?1, respectively. The complexes 1 and 2 exhibit excellent DNA‐‘light switch’ performances, i.e., they do not (or extremely weakly) show luminescence in aqueous solution at room temperature but are strongly luminescent in the presence of DNA. In particular, the experimental results suggest that the ancillary ligands bpy and phen not only have a significant effect on the DNA‐binding affinities of 1 and 2 but also have a certain effect on their spectral properties. [Ru(phen)₂(ppn)]²⁺( 2 ) might be developed into a very prospective DNA‐‘light switch’ complex. To explain the DNA‐binding and spectral properties of 1 and 2 , theoretical calculations were also carried out applying the DFT/TDDFT method.     

A New Samarium(III) Complex of Liriodenine: Synthesis,Crystal Structure,Antitumor Activity,and DNA Binding Study

A novel Sm^III complex [Sm^III(LA)₂(pic)₃] (Hpic = picric acid), in which LA is a natural‐derived alkaloid, liriodenine, was synthesized and characterized by IR, elemental analysis, and single‐crystal X‐ray diffraction analysis. This complex showed enhanced solubility compared with liriodenine and its metal complexes that have been previously reported. The interaction of the Sm^III complex with ct‐DNA was further investigated by various spectroscopic techniques, such as UV/Vis spectroscopy, fluorescence spectroscopy, circular dichroism spectroscopy (CD), and viscosity measurement. The results showed that the intrinsic binding constant K_b of the Sm^III complex with ct‐DNA was calculated to be 5.03 × 10³ L·mol^–1 by UV/Vis absorption spectral analysis. The thermodynamic fluorescent spectral analysis suggested that the fluorescence intensity of the Sm^III complex was weakened by ct‐DNA mainly through a dynamic quenching mechanism. The presence of Sm complex could increase the viscosity of DNA solution, so it was concluded that the complex bound with ct‐DNA via a moderate intercalative mode. Furthermore, this Sm^III complex exhibited significant growth inhibition on the three typical tumor cell lines, HepG2, T‐24, and SK‐OV‐3, with the corresponding IC₅₀ values, 10.76 ± 0.19, 8.85 ± 1.12, and 10.01 ± 0.55 μM, respectively. The in vitro antitumor activity was comparable with LA and cisplatin, which suggested that it might be a new broad spectrum antitumor agent with more satisfying solubility.